Breast Cancer Chemotherapy Can Lead To Subtle Impairment Among Women Who Received CMF Regimen
Dutch investigators have reported that women who received CMF chemotherapy (a combination regimen including the drugs cyclophosphamide, methotrexate, and 5-fluorouracil) for breast cancer between 1976 and 1995 scored worse on cognitive tests than women who never had cancer. The differences in performance were subtle but statistically significant, and occurred mainly in word learning, memory and information processing speed. The findings - published February 27 in the Journal of Clinical Oncology - indicate that cognitive problems, which are known to occur shortly after treatment, may also be observed 20 years after treatment.
Confirming The Efficacy Of CT Colonography As A Front Line Colorectal Cancer Screening Tool For Seniors
Computerized tomographic (CT) colonography (CTC), also known as virtual colonoscopy, is comparable to standard colonoscopy in its ability to accurately detect cancer and precancerous polyps in people ages 65 and older, according to a paper published online in Radiology. This is consistent with results of the ACRIN National CT colonography Trial, published in the New England Journal of Medicine in 2008, which demonstrated CT colonography can serve as a primary colorectal cancer screening option for adults ages 50 and older, but did not specifically break out data for participants ages 65 and older included in the overall analysis.
Nearly 1.3 Million Deaths Predicted From Cancer In The EU In 2012
New figures published today (Wednesday) estimate that there will be nearly 1.3 million deaths from cancer in 2012 in the European Union (EU) - 717, 398 men and 565, 703 women. Although the actual numbers have increased, the rate (age-standardised per 100, 000 population) of people who die from the disease continues to decline. Writing in the cancer journal Annals of Oncology [1], a group of researchers from Italy and Switzerland estimate that the overall cancer death rates will be 139 per 100, 000 men and 85 per 100, 000 women in 2012.